23andMe partners with Stanford researcher on MPN

July 5, 2016

Researchers at Stanford have partnered with the genetic sequencing company 23andMe to study of 726 people with PV, ET and MF, compared to a control population from the 23andMe dataset. Dr. Jason Gotlib reports in Blood that individuals found in the control without an MPN, but with the JAK2 mutation have a predisposition to developing MPN as well as JAK2 V617F clonal hematopoiesis, a more common phenomenon that may foreshadow the development of an overt neoplasm.

http://www.bloodjournal.org/content/early/2016/06/30/blood-2015-06-652941 

Receive updates on the latest MPN news & events.

Find out ways you can help support MPN patients and researchers.

x

NEVER MISS AN UPDATE

Get free, timely information on living with an MPN.

Subscribe